July 15, 2009 3:00 am
Patients with late-stage cancers should gain faster access to innovative treatments under plans unveiled by the government yesterday.
The Office for Life Sciences has earmarked an initial £25m next year for a pilot programme to fund experimental drugs for patients with rare illnesses, ahead of their approval by the government's medicines advisory body.
Lord Drayson, science minister, said the sector could receive a third of the £1bn government-seeded innovation fund unveiled last month, alongside support for green technology and media industries.
Copyright The Financial Times Limited 2015. You may share using our article tools.
Please don't cut articles from FT.com and redistribute by email or post to the web.